Highly inflammatory rheumatoid arthritis patients more susceptible to cognitive impairment

Researchers assessed cognitive function among rheumatoid arthritis patients with ongoing inflammatory activity.

212Pb-DOTAM-GRPR1 by Orano Med for Cervical Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 26, 2023

MindMed’s Phase 2b Trial For MM-120 in GAD Reaches Enrollment Milestone

MindMed (NASDAQ: MNMD) (NEO: MMED), a clinical-stage biopharmaceutical company focused on pioneering innovative treatments for brain health disorders, made a noteworthy announcement today. They have

September 12, 2023

Healthy eating may be a key player in COPD risk reduction

The association between diet quality and the odds of Chronic obstructive pulmonary disease (COPD).

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.